RIPK1 and TRADD Regulate TNF-Induced Signaling and Ripoptosome Formation

Int J Mol Sci. 2021 Nov 18;22(22):12459. doi: 10.3390/ijms222212459.

Abstract

TNF is a proinflammatory cytokine that is critical for the coordination of tissue homeostasis. RIPK1 and TRADD are the main participants in the transduction of TNF signaling. However, data on the cell fate-controlling functions of both molecules are quite controversial. Here, we address the functions of RIPK1 and TRADD in TNF signaling by generating RIPK1- or TRADD-deficient human cell lines. We demonstrate that RIPK1 is relevant for TNF-induced apoptosis and necroptosis in conditions with depleted IAPs. In addition, TRADD is dispensable for necroptosis but required for apoptosis. We reveal a new possible function of TRADD as a negative regulator of NIK stabilization and subsequent ripoptosome formation. Furthermore, we show that RIPK1 and TRADD do not appear to be essential for the activation of MAPK signaling. Moreover, partially repressing NF-κB activation in both RIPK1 and TRADD KO cells does not result in sensitization to TNF alone due to the absence of NIK stabilization. Importantly, we demonstrate that RIPK1 is essential for preventing TRADD from undergoing TNF-induced ubiquitination and degradation. Taken together, our findings provide further insights into the specific functions of RIPK1 and TRADD in the regulation of TNF-dependent signaling, which controls the balance between cell death and survival.

Keywords: NF-κB; NIK; TNF signaling; apoptosis; necroptosis; ripoptosome.

MeSH terms

  • Apoptosis / drug effects
  • Apoptosis / genetics*
  • Baculoviral IAP Repeat-Containing 3 Protein / genetics
  • Baculoviral IAP Repeat-Containing 3 Protein / metabolism
  • CASP8 and FADD-Like Apoptosis Regulating Protein / genetics
  • CASP8 and FADD-Like Apoptosis Regulating Protein / metabolism
  • CRISPR-Cas Systems
  • Cycloheximide / pharmacology
  • Gene Deletion
  • Gene Expression Regulation
  • HeLa Cells
  • Humans
  • I-kappa B Kinase / genetics
  • I-kappa B Kinase / metabolism
  • Inhibitor of Apoptosis Proteins / genetics
  • Inhibitor of Apoptosis Proteins / metabolism
  • NF-kappa B / genetics
  • NF-kappa B / metabolism
  • Necroptosis / drug effects
  • Necroptosis / genetics*
  • Proteasome Endopeptidase Complex / metabolism
  • Receptor-Interacting Protein Serine-Threonine Kinases / deficiency
  • Receptor-Interacting Protein Serine-Threonine Kinases / genetics*
  • Signal Transduction
  • TNF Receptor-Associated Death Domain Protein / deficiency
  • TNF Receptor-Associated Death Domain Protein / genetics*
  • TNF Receptor-Associated Factor 2 / genetics
  • TNF Receptor-Associated Factor 2 / metabolism
  • Tumor Necrosis Factor-alpha / metabolism*
  • Tumor Necrosis Factor-alpha / pharmacology
  • Ubiquitination

Substances

  • CASP8 and FADD-Like Apoptosis Regulating Protein
  • CFLAR protein, human
  • Inhibitor of Apoptosis Proteins
  • NF-kappa B
  • PSMD2 protein, human
  • TNF Receptor-Associated Death Domain Protein
  • TNF Receptor-Associated Factor 2
  • Tumor Necrosis Factor-alpha
  • Cycloheximide
  • BIRC3 protein, human
  • Baculoviral IAP Repeat-Containing 3 Protein
  • RIPK1 protein, human
  • Receptor-Interacting Protein Serine-Threonine Kinases
  • I-kappa B Kinase
  • IKBKE protein, human
  • Proteasome Endopeptidase Complex